United Kingdom· GB-APID-21028111000001109
Acarbose 100mg tablets
A acarbose product containing acarbose, registered in United Kingdom by Arrow Generics Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Acarbose is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BF01 (acarbose), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Acarbose · ATC A10BF01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of acarbose costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.52 in Spain to $1.01 in United States — a ×1.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Acarbose · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$1.01 (acquisition cost)
- IT Italy$0.96
- FR France$0.65
- ES Spain$0.52
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Acarbose
- Manufacturer
- Arrow Generics Ltd
- Country
- United Kingdom (GB)
- ATC code
- A10BF01
- ATC class
- Acarbose
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060034833956
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for acarbose.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acarbose · interactions on record
461 records
- 8 severe
- 262 moderate
- 46 minor
- 145 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- GatifloxacinJ01MA16severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Acarbose in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACARBOSE VIATRISMylan Ireland Limited, Dublin
- United StatesAcarboseStrides Pharma Science Limited
- FranceACARBOSE ARROW 100 mg, comprimé sécableARROW GENERIQUES
- SpainACARBOSA FARMALIDER 100 MG COMPRIMIDOSFarmalider S.A.
- ItalyACARBOSIO DOC GENERICIDOC GENERICI S.R.L.
- PolandAcarbose AurovitasAurovitas Pharma Polska Sp. z o.o.
- CanadaMAR-ACARBOSEMARCAN PHARMACEUTICALS INC
- NorwayAcarbose alALUID PHARMA
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Ароба
- Czechia · Acarbose Viatris
- Germany · Acarbose Al, Acarbose Dura
- Spain · Acarbosa Farmalider, Acarbosa Qualigen
- France · Acarbose Arrow, Acarbose Arrow Lab
- Italy · Acarbosio Aurobindo, Acarbosio Doc Generici
- Poland · Acarbose Aurovitas, Adeksa
- Portugal · Acarbose Berar Laboratórios Basi - Indústria Farmacêutica, Acarbose Bluepharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be8e4201-d395-47b7-8bfc-c4e275a7da62 GET /v1/drugs/be8e4201-d395-47b7-8bfc-c4e275a7da62?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "21028111000001109",
"desc": "Acarbose 100mg tablets (Arrow Generics Ltd)",
"form": "Oral tablet",
"vpid": "42080211000001108",
"source": "dmd",
"vtm_id": "774404008",
"strength": "100 mg",
"substance": "Acarbose",
"ingredient": "Acarbose",
"supplier_code": "10190711000001104"
}See everything about acarbose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.